Follow us...

 

Search News Archives

Channels

News

 

 

View Channel

Laboratory Products

 

 

View Channel

Special Offers and Promotions

 

Microscopy | Image Analysis

 

 

View Channel

Separation Science

 

 

View Channel

Coronavirus (COVID-19)

 

 

View Channel

Research & Case Studies

 

 

View Channel

Conferences | Events
PerkinElmer

PerkinElmer

PerkinElmer

Products

Contact PerkinElmer


If you have not logged into the website then please enter your details below.

All articles from PerkinElmer

  PerkinElmer Launches Cloud Based Solution to Enable Remote Lab Management

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has announced the launch of its PKeye™ Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer instruments and workflows in real-time. The PKeye Workflow Monitor offers scientists and researchers 24/7 access and visibility into their laboratory operations....

 

  Signals Research Suite Accelerates Data Driven Decision Making for Pharmas

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has announced the launch of its Signals Research™ Suite , a full cloud based solution, deployed on Amazon Web Services. The suite is a secure, informatics platform, providing integrated, end-to-end scientific data and workflow management for pharmaceutical and industrial customers. Designed to help drive more informed and accelerated decision making around drug, compound and formulation candidates...

 

  PerkinElmer Receives FDA Emergency Use Authorization for Respiratory SARS-CoV-2 Panel

PerkinElmer, Inc. has announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel 1 assay. Qualified laboratories can immediately begin using this single test for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus (RSV) isolated from nasopharyngeal swabs, anterior nasal swabs and mid-turbinate swabs...

 

  PerkinElmer + Honeycomb Bio unveil a first-of-its-kind HIVE solution for single-cell profiling

PerkinElmer, Inc. and Honeycomb Biotechnologies, Inc., announce the commercial launch of the first of its kind HIVE™ scRNAseq Solution for single-cell isolation and analysis. The HIVE solution leverages a portable, handheld device for the capture, storage and RNA-Seq library preparation of a diverse range of cell types, including fragile and labile cells such as granulocytes, nephrons, hepatocytes and neurons....

 

  PerkinElmer launches next-generation cell image analysis and management software to streamline drug discovery decision-making

PerkinElmer, Inc., a global leading solutions provider in the life sciences, diagnostics, food and environmental testing markets, has announced the launch of Signals Image Artist™ software – a next-generation image analysis and management platform for drug discovery research. The new offering is designed to help scientists accurately process and analyse their high-content screening (HCS) and cellular imaging data in a matter of hours, instead of days or weeks, so they can make more informed decisions faster...

 

  UPM Biomedicals and PerkinElmer collaborate to offer high throughput 3D cell screening solution

UPM Biomedicals is pleased to announce that it has entered into an agreement with PerkinElmer Health Sciences, Inc., for the life sciences leader to act as a distributor of the GrowDex® and GrowDase™ range of products. This new collaboration will offer researchers a complete solution for high throughput screening (HTS) of 3D cell cultures in early drug discovery, bringing together PerkinElmer’s cell imaging and automation solutions and knowledge, and UPM’s animal-free 3D reagent offerings and expertise...
 

 

  PerkinElmer’s COVID-19 RT-PCR Test Kit Receives FDA Emergency Use Authorization for Saliva as Specimen Type

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has announced that the U.S. Food and Drug Administration (FDA) has authorized the PerkinElmer® New Coronavirus Nucleic Acid Detection Kit for an additional indication that permits use of saliva as specimen type. The kit now has Emergency Use Authorization (EUA) for the qualitative detection of nucleic acid from SARS-CoV-2 in saliva specimens collected...

 

  PerkinElmer Expands KRAS Oncology Drug Discovery Assays with New Ready-to-Use AlphaLISA Kits

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has announced four new ready-to-use AlphaLISA® KRAS kits, designed to help scientists better understand complex KRAS protein structures and mutations so they can more easily, quickly, and precisely identify potential new therapeutic candidates for a wide range of prevalent cancers...

 

  PerkinElmer to Acquire Antibody and Reagent Leader BioLegend

PerkinElmer announce it has entered into an agreement to acquire BioLegend, a leading, global provider of life science antibodies and reagents, for approximately $5.25 billion in a combination of cash and stock, subject to certain adjustments. BioLegend provides its academic and biopharmaceutical customers with best-in-class antibodies and reagents in high-growth areas such as cytometry...

 

  PerkinElmer to Acquire UK In-Vitro Diagnostics Company Immunodiagnostic Systems

Through this acquisition, PerkinElmer will be able to grow its overall Diagnostics business and specifically its immunodiagnostics segment. Moreover, the deal will enable PerkinElmer to combine its channel expertise and testing capabilities with IDS’s best-in-class chemiluminescence products in endocrinology, autoimmunity and infectious diseases to better serve customers around the world....

 

  CRISPRi Innovations Provide Expanded Experimental Options and Flexibility For Researchers Facilitating Disease & Drug Research

Horizon Discovery, a PerkinElmer, Inc. company, announce that its gene editing and modulation portfolio is expanding to include a new family of CRISPR modulation (CRISPRmod) reagents for CRISPR interference (CRISPRi). CRISPRi enables scientists to better understand the biological pathways, processes and pathologies of disease by repressing genes at the transcriptional level, ultimately leading to new therapeutic approaches....

 

  PerkinElmer Further Expands Industry-Leading Signals™ Informatics Capabilities in Biologics Drug Discovery

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has announced its industry-leading documentation, workflow and decision making Signals™ informatics platform is being expanded to build on existing capabilities in the biologics drug discovery space. This comes through a collaboration with Insightful Science, a software company serving the global life sciences community....

 

  EUROIMMUN Launches Novel Ultrafast Automated Microscope and Intelligent Software for State-of-the-Art Diagnostics

EUROIMMUN, a PerkinElmer, Inc. company, announce the launch of the EUROPatternTM Microscope Live (EPML) compact immunofluorescence microscope, available with the fourth generation of the Company’s well-established EUROLabOfficeTM 4.0 (ELO 4.0) laboratory management software. The combined system of hardware and software allows for ultrafast automated immunofluorescence image acquisition, pattern recognition and titer estimation as well as modern diagnostics at the screen.

 

  PerkinElmer Completes Acquisition of Oxford Immunotec Global PLC

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has announced that the Company has completed its previously announced acquisition of Oxford Immunotec Global PLC (Oxford Immunotec). PerkinElmer originally announced its intent to acquire Oxford Immunotec on January 7, 2021.

 

  PerkinElmer Launches Comprehensive Solutions for Detecting SARS-CoV-2 Mutations

PerkinElmer, Inc. has announced the launch of two Research Use Only (RUO) solutions, PKamp™ VariantDetect™ SARS-CoV-2 RT-PCR Assay and Next Generation Sequencing-based NEXTFLEX® Variant-Seq™ SARS-CoV-2 Kit. Using nucleic acid extracted from samples that previously tested positive, laboratories can use these assays to identify genomic mutations reported in relation to SARS-CoV-2 variants....

 

  PerkinElmer launches rapid COVID-19 Antigen Test

PerkinElmer Changes COVID-19 Rapid Testing Landscape with Highly Sensitive Point of Care Antigen Test for Mass Screening. PerkinElmer, Inc. has announced the launch of the PerkinElmer® COVID-19 Antigen Test for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in nasal (NS) or nasopharyngeal (NP) swab specimens. The lateral flow immunoassay test can be used to screen or to aid in diagnoses of COVID-19 in asymptomatic or symptomatic individuals....

 

  PerkinElmer Launches First Cell Painting Kit

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has launched the first cell painting kit as part of its new portfolio of PhenoVue™ cellular imaging reagents. This new range of reagents leverages PerkinElmer’s expertise in cellular imaging and high-content screening and works alongside the Company’s microplates, automation, software and industry-leading high-content screening instruments....

 

  How Digital is Transforming R&D Thinking at Novartis, Roche, Merck and more

"Transforming R&D: Digital innovation in the pharmaceuticals and chemicals industries," a new report by MIT Technology Review Insights, explores how leading pharmaceuticals and chemicals companies are using artificial intelligence, quantum computing, and other digital technologies to transform scientific research and enhance R&D performance. The report, produced in association with PerkinElmer Informatics, is based on in-depth interviews with R&D executives at organizations including Novartis, Roche, Merck, BASF, and Syngenta....

 

  PerkinElmer SARS-CoV-2 RT-PCR Assay Receives FDA EUA for Asymptomatic Testing

PerkinElmer, Inc. has announced that its PerkinElmer® New Coronavirus Nucleic Acid Detection Kit received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) to test individuals without symptoms or other reasons to suspect COVID-19 infection. According to a new model from The Journal of the American Medical Association’s Open Network developed by researchers from the Centers for Disease Control and Prevention, close to 60% of total COVID-19 transmissions....

 

  PerkinElmer to Acquire Oxford Immunotec Global PLC

Through this Acquisition, PerkinElmer will grow its portfolio of advanced infectious disease testing solutions to include tuberculosis detection to better serve customers around the world. Moreover, the deal will enable PerkinElmer to combine its channel expertise and leading workflow and testing capabilities with Oxford Immunotec’s leading proficiencies in T cell immunology with its proprietary test kits for latent tuberculosis....

 

  Charnwood Lighthouse Lab Goes Live Processing Thousands of COVID-19 Tests per Day with PerkinElmer Solutions

PerkinElmer, Inc., announce that the Lighthouse Lab in Charnwood, Loughborough, England is now processing COVID-19 testing samples as part of the Company’s collaboration with the Department of Health and Social Care (DHSC) in support of the UK Government’s NHS Test and Trace program. The facility, operated by PerkinElmer Genomics, began processing samples and with its team of 400 scientists, researchers, technicians and operations personnel, has the capacity to test up to 50,000 samples daily by early 2021....

 

  PerkinElmer Brings ChemDraw Software to the Cloud, Enhancing Search and Collaboration Workflow

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has launched its newest ChemDraw® application, ChemOffice®+ Cloud, to simplify, facilitate and accelerate chemistry communication workflows. The ChemDraw platform is the leading chemistry drawing tool trusted around the world by scientists in commercial, government and academic lab settings across a number of research areas including life sciences, enviromental and materials....

 

  EUROIMMUN Launches Quantitative ELISA to Measure SARS-CoV-2 Antibodies Against Viral S1 Protein

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced today that EUROIMMUN, a PerkinElmer company, has launched the Anti-SARS-CoV-2 about ELISA (IgG) to quantify IgG antibodies against the SARS-CoV-2 S1 antigen. The assay is available for countries accepting the CE mark, and the Company plans to file a request for this product with the U.S. Food and Drug...

 

  PerkinElmer COVID-19 Test Kit Receives FDA Emergency Use Authorization for Sample Pooling

PerkinElmer, Inc. has announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) to allow sample pooling with PerkinElmer® New Coronavirus Nucleic Acid Detection Kit to increase the number of individuals who can be tested without increasing resources. This validation of batch testing using the industry’s most sensitive assay to date according to the FDA Reference Panel leverages its proven ability to detect low amounts of viral genetic material....

 

  PerkinElmer Receives CE Mark for Multi-analyte Respiratory Panel Including COVID-19

PerkinElmer, Inc. has announced  that its PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel has received clearance to be marketed as an in vitro diagnostic (IVD) device in more than 30 countries by meeting the requirements of the European In Vitro Diagnostic Directive (IVDD). This test is currently under review by the U.S. FDA for Emergency Use Authorization (EUA). The multi-analyte panel enables labs to detect and differentiate between SARS-CoV-2, influenza A viruses, influenza B viruses and respiratory syncytial virus (RSV) in a single test...

 

  Newport, Wales Laboratory Goes Live as First Lighthouse Lab featuring PerkinElmer’s COVID-19 Solutions

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has announced that the first Turnkey Lighthouse lab in Newport, South Wales, is now processing COVID-19 testing samples as part of the Company’s collaboration with the Department of Health and Social Care (DHSC) in support of the UK Government’s Test and Trace strategy...

 

  PerkinElmer Enhances Hand Sanitizer Analyzer to Detect Methanol in 30 Seconds or Less

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has announced that its Hand Sanitizer Analyzer instrument can be used to test for the presence of methanol in alcohol-based hand sanitizer products with pass/fail results delivered in 30 seconds or less. Recent warnings and recalls from the FDA indicate that methanol can be toxic to consumers if absorbed through the skin and life threatening if ingested...

 

  PerkinElmer Releases New Dried Blood Spot Based COVID-19 Serology Test

PerkinElmer, Inc. a global leader committed to innovating for a healthier world, has announced the launch of a dry blood spot (DBS) based test for SARS-CoV-2 IgG using its GSP®/DELFIA® platform, enabling processing of up to 5,000 samples per day. The finger-prick sample collection device allows for both decentralized sample collection and high-throughput testing. The product is being marketed as a CE-IVD test, and the Company plans to apply for....

 

  Global Collaboration Establishes Wales’ National COVID-19 Testing Laboratory

An advanced laboratory dedicated to leading Wales’ national Covid-19 testing has been established in Cardiff, thanks to collaboration between Public Health Wales and one of the world’s leading diagnostics companies. Creating a national Covid-19 testing lab at the University Hospital of Wales is an important part of the Welsh Government’s Test, Trace, Protect strategy and has been made possible thanks to the support...

 

  How PerkinElmer is Helping Combat COVID-19

PerkinElmer, Inc. is actively working with our global customers – which include specialty and reference diagnostic labs, clinics, hospitals, pharmaceutical and biopharmaceutical labs, academia, and governmental and research institutes – to combat the pandemic. Our innovative detection, workflow, and research solutions are being used to drive better outcomes as the world responds to COVID-19....

 

  FDA Provides Emergency Use Authorization to PerkinElmer for Serological Test to Identify COVID-19 Antibodies

U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for EUROIMMUN’s (a PerkinElmer company) Anti-SARS-CoV-2 ELISA (IgG) serology test. Clinical laboratories certified to perform high complexity tests under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this ELISA for the detection of antibodies of the immunoglobulin class G....

 

  Beaumont Health launches largest serological testing study for COVID-19 antibodies in the USA

Beaumont Health’s Research Institute is launching America’s largest serological testing study to help answer many questions surrounding the spread of COVID-19 and potentially help treat patients battling the virus. New study aims to determine the total population with COVID-19 antibodies across a health system, identify potential convalescent plasma donors, better understand disease transmission and contribute to a scientifically-based methodology for returning people to work....

 

  New Coronavirus RT-PCR test by PerkinElmer recieves Emergency Use Authorization (EUA) by U.S. Food and Drug Administration (FDA)

Clinical laboratories certified under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this kit to detect SARS-CoV-2, the virus that causes COVID-19. PerkinElmer’s RT-PCR test is marketed as an in vitro diagnostic (IVD) device by meeting the requirements of the European In Vitro Diagnostic Directive (IVDD) and is available in over 30 countries worldwide....

 

  PerkinElmer Unveils Advanced Drug Discovery and Disease Research Solutions at SLAS2020

PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has introduced new workstations and a high content screening system at SLAS2020 in San Diego. These technologies automate workflows so that disease research and drug discovery professionals can improve productivity, increase reproducibility, and garner key insights. PerkinElmer highlighted these new systems, along with several key offerings from its comprehensive portfolio of instruments and reagents....

 

  PerkinElmer Receives CE-IVD Mark for Its Vanadis Fully Automated NIPT Platform
perkinelmer

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, has announced that its Vanadis® NIPT system has obtained CE-IVD mark for commercialization and distribution throughout Europe and other countries that accept CE marking. This non-invasive test provides screening results for trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome)....

 

  PerkinElmer to Support Research Study in Brazil Focused on Prediction of Preeclampsia

perkin elmerPerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that a collaboration for a prospective study in Brazil aiming to validate the Fetal Medicine Foundation’s (FMF’s) algorithm for pre-term preeclampsia.  The FMF algorithm, which is based on a European population, will now be applied to a study group representative of the Brazilian population....

 

  PerkinElmer Launches NEXTflex® Unique Dual Index Barcodes for Increased Confidence in Sequencing Data

Industry-Leading Adapters Mitigate Index Hopping and Spread of Signal in Next Gen Sequencing Applications. PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has announced its NEXTflex® unique dual index barcodes, the latest addition to the NEXTflex family of library prep solutions....

 

  PerkinElmer Collaborates with Helix to Drive Innovation in Exome-Based Personal Genomics

perkinelmerFirst Personal Genomics Product Will Focus on 59 Genes Identified by the American College of Medical Genetics and Genomics (ACMG) as Highly Penetrant. PerkinElmer, Inc. has announced  a collaboration with Helix, a personal genomics company, to develop and commercialize exome sequencing-based tests...

 

  Parent Project Muscular Dystrophy Selects PerkinElmer to Support Decode Duchenne Program

perkin elmerPerkinElmer, Inc., a global leader committed to innovating for a healthier world, has announced that Parent Project Muscular Dystrophy (PPMD) has selected the Company to provide genetic testing for its Decode Duchenne program...

 

  Groundbreaking Research Reveals Accuracy of PerkinElmer's High Volume NIPT Platform

PerkinElmerStudy Results in Leading Scientific Publication Underscores Value of PerkinElmer’s Vanadis NIPT Solution. PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has announced the publication of a research study describing the technology behind the Vanadis NIPT system. The article titled “Imaging Single DNA Molecules for High Precision NIPT” was published online in Nature Scientific Reports...

 

  PerkinElmer Launches chemagic Prime Instrument for Automated Nucleic Acid Isolation and Assay Set-Up

Leverages Advanced Magnetic Bead-Based Technology to Support Next Gen Sequencing, Genotyping, PCR and MLPA in Human Samples  

perkinelmerPerkinElmer, Inc., has announced the launch of its chemagic™ Prime™ instrument, a new streamlined, walk-away sample processing solution which offers automated nucleic acid isolation and assay setup by combining PerkinElmer’s chemagic™ 360 instrument with the JANUS® automated liquid handling system....

 

  PerkinElmer and In-Depth Genomics Team Up for Whole Genome Sequencing Diagnostic Program for Rare Diseases

In-Depth Genomics Leverages PerkinElmer’s Comprehensive Sequencing Services to Provide Whole Genome Sequencing to Neurology Patients 

perkinelmerPerkinElmer, Inc., a global leader committed to innovating for a healthier world, have announced an innovative collaboration with In-Depth Genomics (IDG) to support IDG’s Whole Genome Sequencing (WGS) Diagnostic Program that will bring genetic diagnosis.....

 

  PerkinElmer Launches QSight210 MD System for Clinical Laboratories

High Throughput Mass Spectrometry-Based Clinical Solution Can Run Hundreds of Samples Per Day 

QSight 210 MD systemPerkinElmer, Inc.has announced the launch of its QSight® 210 MD system, designed to provide routine high throughput quantitation to laboratories. The QSight 210 MD system includes tandem mass spectrometry (MSMS) technology designed to enable laboratories to run hundreds of samples per day....

 

  Introducing PerkinElmer’s NEW Spectrum Two N FT-NIR

From field to lab to the loading dock, the perfect system for NIR materials testing.

PerkinElmer’s NEW Spectrum Two N™ FT-NIRWhether you’re performing ID testing or quantitative analysis for food, pharmaceuticals, polymers, or petroleum, you often need to test where the samples are – onsite, and on the fly. But you can’t sacrifice high performance for portability – which means your FT-NIR needs to deliver the same levels of sensitivity, resolution, and throughput, inside and outside the lab....

 

  The New Spectrum Two N FT NIR from PerkinElmer

Innovative Molecular Spectroscopy Solution Provides Advanced Analysis for Food, Pharma and Industrial Applications

Spectrum Two N FT NIR PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of the Spectrum Two N™ FT-NIR system. This instrument is designed for laboratory technicians and staff conducting molecular spectroscopy analysis on a wide range of pharmaceutical, food and industrial samples....

 

  PerkinElmer Launches Clinical Whole Genome Sequencing Services

PerkinElmer Genetics Provides Complete Genomic Lab Testing Solution

perkinelmerPerkinElmer, Inc. announce the launch of PerkinElmer Genetics' clinical genomics services. Through its integrated laboratories in the U.S., India and China, PerkinElmer offers a global genomic lab testing platform that performs screening and diagnostic testing, specializing in newborn screening....

 

  Introducing PerkinElmer’s NEW Avio 500 ICP -OES

Expand the range of what your lab can accomplish. Extend your resources so that you can do even more.

Avio 500 ICP-OESAll with the Avio 500 ICP-OES – a truly simultaneous, dual view, and compact ICP-OES. It utilizes a vertical plasma and is engineered to handle even the most difficult, high-matrix samples without dilution, delivering productivity, performance, and faster return on investment....

 

  Groundbreaking Multi-Center Clinical Trial Confirms Low-Dose Aspirin Therapy Reduces Rate of Pre-Term Preeclampsia

Project “ASPRE” Study Utilized PerkinElmer’s DELFIA Xpress PlGF 1-2-3 Assay to Identify Women who Would Benefit from Low-Dose Aspirin

perkinelmerPerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the publication of the Fetal Medicine Foundation’s (FMF’s) Project “ASPRE” study results in The New England Journal of Medicine. These compelling findings revealed that administering low-dose aspirin (150 mg) led to a 62% reduction in the rate of pre-term preeclampsia....

 

  PerkinElmer Launches NeoLSD MSMS Kit

First Commercial IVD Kit to Use Mass Spectrometry to Screen for Six LSDs in Newborn Babies from a Single Dried Blood Spot Sample

perkinelmerPerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its new NeoLSD™ MSMS kit.  This solution is the first CE marked commercial in vitro diagnostic (IVD) kit to utilize mass spectrometry instrumentation for the six most commonly screened lysosomal storage disorders (LSDs)....

 

  PerkinElmer to Acquire EUROIMMUN for Approximately $1.3 Billion

PerkinElmer, Inc. have announced that it has entered into a definitive agreement to acquire EUROIMMUN Medical Laboratory Diagnostics AG. The agreement provides that PerkinElmer will acquire up to a 100% stake in EUROIMMUN.

perkinelmerThe total purchase price of the transaction based on all outstanding shares being acquired will be approximately $1.3 billion in cash.Based in Lübeck, Germany, with approximately 2,400 employees, EUROIMMUN is widely recognized as a global leader in autoimmune testing and an emerging force in infectious disease and allergy testing.....

 

  New Study Published in Clinical Chemistry Evaluates Biomarker for Duchenne Muscular Dystrophy Screening in Newborn Babies

PerkinElmer, Inc. Provides Research-Use-Only Automated Immunoassay to Detect Creatine Kinase Muscle Isozyme in Dried Blood Spots

perkinelmerA new study published in Clinical Chemistry has revealed a potential automated assay for identifying Duchenne muscular dystrophy (Duchenne) in newborn babies. Duchenne is a progressive, X-chromosome linked neuromuscular disorder with a worldwide average incidence rate of approximately 1 in 5,000 babies....

 

  PerkinElmer’s New QSight Triple Quadrupole LC/MS/MS System Delivers High Sensitivity and Enhanced Productivity for Analytical Labs

PerkinElmer Highlights Innovative Mass Spectrometry and Liquid & Gas Chromatography Technologies for Food, Environmental and Industrial Customers at analytica China

Torion T-9PerkinElmer, Inc., a global leader committed to innovating for a healthier world, has announced the launch of its new QSight™ Triple Quadrupole LC/MS/MS instrument at a press conference during analytica China, the international trade fair for laboratory technology, analysis, biotechnology and diagnostics held at the Shanghai New International Expo Centre....

 

  PerkinElmer Display Laboratory Technologies for Environmental and Human Health Researchers at Analytica 2016

Advanced Detection, Imaging and Diagnostics Solutions for Today’s Modern Laboratory

PerkinElmerWHAT: PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it will showcase several of its innovative solutions at Analytica 2016, the international trade fair for laboratory technology, analysis and biotechnology in Munich, Germany. “We are pleased to highlight our wide range of instruments, software and services with this...

 

  Magritek announce expansion with new sales hires

Magritek announces company expansion with the appointment of new hires to the sales and marketing team. 

John Paul Cerroti will lead marketing efforts out of the Aachen while Silverio Iacono heads up sales operations worldwide from his East Coast US baseMagritek, a leading provider of compact NMR and MRI instruments, are pleased to announce further expansion in company activities worldwide. With offices now in the USA, Germany & New Zealand, the company has added experienced leaders in instrumentation sales and product marketing. With increased growth in worldwide markets for benchtop-sized analytical techniques, Magritek, leading providers of compact NMR and MRI systems, are pleased to be announcing the addition of two experienced industry professionals to their sales and marketing team...

 

  PerkinElmer Receives CE Mark for First Commercially Available Newborn Screen in Europe & the Middle East for Severe Combined Immunodeficiency

SCID screening improves medical outcomes with early detection, intervention

Newborn Screen headerPerkinElmer, Inc., a global leader in improving the health and safety of people and the environment, today introduced the first commercially available screening test for Severe Combined Immunodeficiency (SCID). The EnLite™ Neonatal TREC System expands the newborn screening portfolio of commercially available tests and will be introduced under CE marking, for sale in select countries in Europe and the Middle East. SCID impacts an estimated 1 in 50,000 to 1 in 100,000 newborns globally every year...

 

  PerkinElmer Introduces New Generation of Tandem Mass Spectrometer

The New AxION iQT GC/MS/MS System Combines the Quantitative Power of a Triple Quad with the Identification Capabilities of a Q-TOF in a Faster, Modular and Easier to Operate Instrument

PerkinElmer AxION iQT GCMSMSAt the 2013 American Society for Mass Spectrometry Conference, PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, introduced the AxION iQT gas chromatography tandem mass spectrometer (GC/MS/MS). The AxION iQT system provides greater quantitative capabilities to that of a triple quadrupole, while quickly identifying compounds like a quadrupole time-of-flight (Q-TOF) at a rate of up to 500 compounds per second. The new mass spectrometer provides laboratories with easier to use technology, faster results, and more specific, selective data needed to make more accurate decisions faster.....

 

  PerkinElmer Launches New OneSource Laboratory Consulting Services to Drive Improved Laboratory Efficiencies

New consulting services will leverage expertise derived from the largest laboratory services and informatics offering install base

onesourcePerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced today that it is expanding its OneSource® Laboratory Services offering to include strategic laboratory consulting services. OneSource® Strategic Lab Solutions will deliver the combined power of PerkinElmer's expertise in informatics, instrumentation, service and process optimization, to increase laboratories' productivity and performance....

 

  PerkinElmer Showcases Latest Advancements in Thermal Instrumentation at Materials Research Society Meeting

New, unique offerings enable scientists to analyze environmental and industrial samples with greater specificity

The TL-9000

PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, displayed two new hyphenated thermal analysis solutions at the Materials Research Society Meeting that are designed for the accurate characterization and analysis of inorganic materials, polymers, geological materials and oils.

 

  PerkinElmer Launches the EnSpire Multimode Plate Reader with Label-Free Detection Technology for Drug Discovery Research PerkinElmer  EnSpire® Multimode Plate Reader PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the introduction of the EnSpire® Multimode Plate Reader with Corning® Epic® label-free technology. This is the first and only benchtop detection platform to combine optical label-free technology and traditional labeled assays to accurately identify and characterize potential new therapeutic targets.

 

  PerkinElmer Launches Next Generation DNA Sequencing and Analysis Services perkinelmerPerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of its next generation DNA sequencing and data analysis services, to enable researchers to better explore the genomic origins of disease

 

  Discover the best complete solution for the analysis of Residual Solvents! With the PerkinElmer Clarus 680 GC and TurboMatrix HS 40 you can comply with the USP 467 method.(Class I, II and III solvents; Procedure A, B, C: screening, confirmation, quantitation).